Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
Khan O, Rieckmann P, Boyko A, Selmaj K, Ashtamker N, Davis MD, Kolodny S, Zivadinov R. Khan O, et al. Among authors: ashtamker n. Mult Scler. 2017 May;23(6):818-829. doi: 10.1177/1352458516664033. Epub 2016 Aug 8. Mult Scler. 2017. PMID: 27503905 Clinical Trial.
Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study.
Rieckmann P, Zivadinov R, Boyko A, Selmaj K, Alexander JK, Kadosh S, Rubinchick S, Bernstein-Hanlon E, Stark Y, Ashtamker N, Davis MD, Khan O. Rieckmann P, et al. Among authors: ashtamker n. Mult Scler J Exp Transl Clin. 2021 Dec 13;7(4):20552173211061550. doi: 10.1177/20552173211061550. eCollection 2021 Oct. Mult Scler J Exp Transl Clin. 2021. PMID: 34925876 Free PMC article.
The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20-Year Data from the U.S. Glatiramer Acetate Extension Study.
Khan O, Seraji-Bozorgzad N, Bao F, Razmjou S, Caon C, Santiago C, Latif Z, Aronov R, Zak I, Ashtamker N, Kolodny S, Ford C, Sidi Y. Khan O, et al. Among authors: ashtamker n. J Neuroimaging. 2017 Jan;27(1):97-106. doi: 10.1111/jon.12358. Epub 2016 May 23. J Neuroimaging. 2017. PMID: 27214389 Free PMC article. Clinical Trial.
Medical cannabis for pain management in patients undergoing chronic hemodialysis: randomized, double-blind, cross-over, feasibility study.
Kliuk-Ben Bassat O, Schechter M, Ashtamker N, Yanuv I, Rozenberg A, Hirshberg B, Grupper A, Vaisman N, Brill S, Mosenzon O. Kliuk-Ben Bassat O, et al. Among authors: ashtamker n. Clin Kidney J. 2022 Dec 23;16(4):701-710. doi: 10.1093/ckj/sfac275. eCollection 2023 Apr. Clin Kidney J. 2022. PMID: 37007688 Free PMC article.